Applied Dna Sciences Inc (NASDAQ: APDN) kicked off on Tuesday, down -7.78% from the previous trading day, before settling in for the closing price of $0.14. Over the past 52 weeks, APDN has traded in a range of $0.12-$11.76.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 60.75%. While this was happening, its average annual earnings per share was recorded 73.63%. With a float of $51.42 million, this company’s outstanding shares have now reached $54.11 million.
Let’s determine the extent of company efficiency that accounts for 48 employees. In terms of profitability, gross margin is 34.35%, operating margin of -353.23%, and the pretax margin is -230.85%.
Applied Dna Sciences Inc (APDN) Breakdown of a Key Holders of the stock
Our next focus will be how large-scale investors are participating in this stock of the Diagnostics & Research Industry. The insider ownership of Applied Dna Sciences Inc is 6.82%, while institutional ownership is 39.58%.
Applied Dna Sciences Inc (APDN) Recent Fiscal highlights
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.05 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 73.63% per share during the next fiscal year.
Applied Dna Sciences Inc (NASDAQ: APDN) Trading Performance Indicators
Take a look at Applied Dna Sciences Inc’s (APDN) current performance indicators. Last quarter, stock had a quick ratio of 4.53. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.89.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -5.72, a number that is poised to hit -0.06 in the next quarter and is forecasted to reach -0.11 in one year’s time.
Technical Analysis of Applied Dna Sciences Inc (APDN)
Looking closely at Applied Dna Sciences Inc (NASDAQ: APDN), its last 5-days average volume was 1.34 million, which is a drop from its year-to-date volume of 2.78 million. As of the previous 9 days, the stock’s Stochastic %D was 9.16%. Additionally, its Average True Range was 0.01.
During the past 100 days, Applied Dna Sciences Inc’s (APDN) raw stochastic average was set at 2.48%, which indicates a significant decrease from 4.56% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 51.45% in the past 14 days, which was lower than the 148.35% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.1804, while its 200-day Moving Average is $0.5596. However, in the short run, Applied Dna Sciences Inc’s stock first resistance to watch stands at $0.1337. Second resistance stands at $0.1393. The third major resistance level sits at $0.1437. If the price goes on to break the first support level at $0.1237, it is likely to go to the next support level at $0.1193. Now, if the price goes above the second support level, the third support stands at $0.1137.
Applied Dna Sciences Inc (NASDAQ: APDN) Key Stats
The company with the Market Capitalisation of 7.06 million has total of 55,189K Shares Outstanding. Its annual sales at the moment are 3,430 K in contrast with the sum of -6,990 K annual income. Company’s last quarter sales were recorded 1,200 K and last quarter income was -2,640 K.
